Childhood vaccination schedule: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Mehdi Pahlavani (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
5,087 edits
Mehdi Pahlavani (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators
5,087 edits
Line 28: Line 28:
! align="center" style="background:#4479BA; color: #FFFFFF;" |17-18 yrs
! align="center" style="background:#4479BA; color: #FFFFFF;" |17-18 yrs
|-
|-
|align="center" style="background:#DCDCDC;"|Hepatitis B1 (HepB)
|align="center" style="background:#DCDCDC;"|Hepatitis B<sup>1</sup> (Hep B)
|style="background: #F0E68C; padding: 5px text-align:center" |1st dose
|style="background: #F0E68C; padding: 5px text-align:center" |1st dose
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
| colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
Line 35: Line 35:
| colspan="8" style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="8" style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Rotavirus2 (RV) RV1 (2-dose series);
|align="center" style="background:#DCDCDC;"|Rotavirus<sup>2</sup> (RV) RV1 (2-dose series);
RV5 (3-dose series)
RV5 (3-dose series)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 55: Line 55:
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|-
|-
|align="center" style="background:#DCDCDC;"|Diphtheria, tetanus, & acellular pertussis3
|align="center" style="background:#DCDCDC;"|Diphtheria, tetanus, & acellular pertussis<sup>3</sup>
(DTaP: <7 yrs)
(DTaP: <7 yrs)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 72: Line 72:
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|-
|-
|align="center" style="background:#DCDCDC;"|Haemophilus influenzae type b4 (Hib)
|align="center" style="background:#DCDCDC;"|Haemophilus influenzae type b<sup>4</sup> (Hib)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 84: Line 84:
| colspan="5" style="background: #DCDCDC; padding: 5px text-align:center" |
| colspan="5" style="background: #DCDCDC; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Pneumococcal conjugate5 (PCV13)
|align="center" style="background:#DCDCDC;"|Pneumococcal conjugate<sup>5</sup> (PCV13)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 95: Line 95:
| colspan="5" style="background: #DCDCDC; padding: 5px text-align:center" |
| colspan="5" style="background: #DCDCDC; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Inactivated poliovirus6 (IPV: <18 yrs)
|align="center" style="background:#DCDCDC;"|Inactivated poliovirus<sup>6</sup> (IPV: <18 yrs)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 105: Line 105:
| colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Influenza7 (IIV)
|align="center" style="background:#DCDCDC;"|Influenza<sup>7</sup> (IIV)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 113: Line 113:
| colspan="4" align="center" style="background: #F0E68C; padding: 5px text-align:center" |Annual vaccination (IIV) 1 dose only
| colspan="4" align="center" style="background: #F0E68C; padding: 5px text-align:center" |Annual vaccination (IIV) 1 dose only
|-
|-
|align="center" style="background:#DCDCDC;"|Measles, mumps, rubella8 (MMR)
|align="center" style="background:#DCDCDC;"|Measles, mumps, rubella<sup>8</sup> (MMR)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 124: Line 124:
| colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Varicella9 (VAR)
|align="center" style="background:#DCDCDC;"|Varicella<sup>9</sup> (VAR)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 136: Line 136:
| colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Hepatitis A1 0 (HepA)
|align="center" style="background:#DCDCDC;"|Hepatitis A<sup>10</sup> (Hep A)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 152: Line 152:
|style="background: #AFEEEE; padding: 5px text-align:center" |
|style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Meningococcal1 1 (Hib-MenCY >6 weeks;  
|align="center" style="background:#DCDCDC;"|Meningococcal<sup>11</sup> (Hib-MenCY >6 weeks;  
MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)
MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 162: Line 162:
|style="background: #AFEEEE; padding: 5px text-align:center" |
|style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Tetanus, diphtheria, & acellular pertussis12 (Tdap: >7 yrs)
|align="center" style="background:#DCDCDC;"|Tetanus, diphtheria, & acellular pertussis<sup>12</sup> (Tdap: >7 yrs)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 179: Line 179:
| colspan="3" style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="3" style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Human papillomavirus1 3 (HPV)
|align="center" style="background:#DCDCDC;"|Human papillomavirus<sup>13</sup> (HPV)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 196: Line 196:
| colspan="3" colspan="3" style="background: #AFEEEE; padding: 5px text-align:center" |
| colspan="3" colspan="3" style="background: #AFEEEE; padding: 5px text-align:center" |
|-
|-
|align="center" style="background:#DCDCDC;"|Meningococcal B1 1
|align="center" style="background:#DCDCDC;"|Meningococcal B<sup>11</sup>
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
Line 211: Line 211:
| colspan="5" align="center" style="background: #DCDCDC; padding: 5px text-align:center" |See footnote 11
| colspan="5" align="center" style="background: #DCDCDC; padding: 5px text-align:center" |See footnote 11
|-
|-
|align="center" style="background:#DCDCDC;"|Pneumococcal polysaccharide5 (PPSV23)
|align="center" style="background:#DCDCDC;"|Pneumococcal polysaccharide<sup>5</sup> (PPSV23)
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |
|style="background:#F8F8FF; |

Revision as of 19:38, 11 April 2017

Template:Vaccination schedule Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Childhood vaccination schedule

The following table summarizes the vaccination schedule for Adolescents Aged 18 Years or Younger based on CDC 2017 recommendation.

Vaccine Birth 1 mo 2 mos 4 mos 6 mos 9 mos 12 mos 15 mos 18 mos 19-23 mos 2-3 yrs 4-6 yrs 7-10 yrs 11-12 yrs 13-15 yrs 16 yrs 17-18 yrs
Hepatitis B1 (Hep B) 1st dose 2nd dose 3rd dose
Rotavirus2 (RV) RV1 (2-dose series);

RV5 (3-dose series)

1st dose 2nd dose See footnote 2
Diphtheria, tetanus, & acellular pertussis3

(DTaP: <7 yrs)

1st dose 2nd dose 3rd dose 4th dose 5th dose
Haemophilus influenzae type b4 (Hib) 1st dose 2nd dose See footnote 4 3rd or 4th dose,

See footnote 4

Pneumococcal conjugate5 (PCV13) 1st dose 2nd dose 3rd dose 4th dose
Inactivated poliovirus6 (IPV: <18 yrs) 1st dose 2nd dose 3rd dose 4th dose
Influenza7 (IIV) Annual vaccination (IIV) 1 or 2 doses Annual vaccination (IIV) 1 dose only
Measles, mumps, rubella8 (MMR) See footnote 8 1st dose 2nd dose
Varicella9 (VAR) 1st dose 2nd dose
Hepatitis A10 (Hep A) 2-dose series, See footnote 10
Meningococcal11 (Hib-MenCY >6 weeks;

MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)

See footnote 11 1st dose 2nd dose
Tetanus, diphtheria, & acellular pertussis12 (Tdap: >7 yrs) Tdap
Human papillomavirus13 (HPV) See footnote 13
Meningococcal B11 See footnote 11
Pneumococcal polysaccharide5 (PPSV23) See footnote 5

See also

Sources and notes

External links

  • National Center for Immunization and Respiratory Diseases. "CDC National Immunization Program". CDC. Retrieved 2006-09-18.
  • "MMR vaccine and the autism epidemic: In a compulsory inoculation program, it is the responsibility of the developers, promoters and enforcers to prove safety and efficacy". MMR vaccine and the autism epidemic. InformedChoice.info. Retrieved 2006-09-18.
  • National Health Service of UK. "UK Immunisation Schedule and Information". NHS. Retrieved 2006-11-03.

Template:Vaccines

de:Impfkalender id:Jadwal imunisasi


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Childhood_vaccination_schedule&oldid=1306443"